Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Kidney Transplantation | 32 | 2021 | 5397 | 4.39 | Why? |
| Transplant Recipients | 10 | 2021 | 4982 | 1.24 | Why? |
| Polyomavirus Infections | 5 | 2019 | 156 | 1.19 | Why? |
| Tumor Virus Infections | 2 | 2019 | 127 | 0.86 | Why? |
| Atypical Hemolytic Uremic Syndrome | 1 | 2021 | 62 | 0.84 | Why? |
| Kidney Diseases | 3 | 2019 | 1434 | 0.76 | Why? |
| Abatacept | 1 | 2020 | 192 | 0.73 | Why? |
| Registries | 8 | 2021 | 12327 | 0.72 | Why? |
| Graft Rejection | 5 | 2021 | 1766 | 0.69 | Why? |
| Lymphoproliferative Disorders | 1 | 2017 | 110 | 0.62 | Why? |
| BK Virus | 4 | 2019 | 135 | 0.53 | Why? |
| France | 14 | 2021 | 12074 | 0.51 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.47 | Why? |
| Immunosuppressive Agents | 6 | 2021 | 6331 | 0.46 | Why? |
| Brain Diseases | 2 | 2021 | 1463 | 0.46 | Why? |
| Carcinoma, Renal Cell | 1 | 2018 | 545 | 0.44 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.42 | Why? |
| Kidney Neoplasms | 1 | 2018 | 832 | 0.39 | Why? |
| Kidney Failure, Chronic | 4 | 2020 | 3222 | 0.38 | Why? |
| Waiting Lists | 3 | 2021 | 1388 | 0.35 | Why? |
| Proteomics | 1 | 2019 | 2481 | 0.34 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.34 | Why? |
| Postoperative Complications | 3 | 2020 | 5861 | 0.33 | Why? |
| Graft Survival | 4 | 2019 | 587 | 0.30 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.26 | Why? |
| Epidemics | 2 | 2021 | 6407 | 0.26 | Why? |
| Viremia | 3 | 2019 | 1020 | 0.25 | Why? |
| Brain | 4 | 2021 | 5133 | 0.25 | Why? |
| RNA, Messenger | 3 | 2021 | 5131 | 0.24 | Why? |
| Renal Replacement Therapy | 2 | 2021 | 1530 | 0.23 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 9335 | 0.23 | Why? |
| Isoantigens | 1 | 2019 | 21 | 0.20 | Why? |
| Blood-Brain Barrier | 2 | 2021 | 531 | 0.20 | Why? |
| Transplantation, Homologous | 2 | 2019 | 757 | 0.19 | Why? |
| Cyclosporine | 2 | 2020 | 449 | 0.19 | Why? |
| HLA-DQ Antigens | 1 | 2019 | 48 | 0.19 | Why? |
| Aged | 19 | 2021 | 215776 | 0.19 | Why? |
| Calcium Oxalate | 1 | 2018 | 14 | 0.19 | Why? |
| Hyperoxaluria, Primary | 1 | 2018 | 15 | 0.19 | Why? |
| Ilium | 1 | 2018 | 22 | 0.19 | Why? |
| Deprescriptions | 1 | 2020 | 294 | 0.19 | Why? |
| Nephrocalcinosis | 1 | 2018 | 14 | 0.19 | Why? |
| Torque teno virus | 1 | 2019 | 73 | 0.18 | Why? |
| Humans | 41 | 2021 | 930598 | 0.18 | Why? |
| DNA Virus Infections | 1 | 2019 | 88 | 0.18 | Why? |
| Brain Edema | 1 | 2020 | 224 | 0.18 | Why? |
| Polyomavirus | 1 | 2018 | 37 | 0.18 | Why? |
| Middle Aged | 21 | 2021 | 270681 | 0.18 | Why? |
| Mycophenolic Acid | 1 | 2020 | 383 | 0.18 | Why? |
| Meningoencephalitis | 1 | 2020 | 208 | 0.17 | Why? |
| Antibody Formation | 2 | 2021 | 4038 | 0.17 | Why? |
| Drug Substitution | 2 | 2019 | 385 | 0.17 | Why? |
| HLA-C Antigens | 1 | 2018 | 195 | 0.17 | Why? |
| Male | 23 | 2021 | 367725 | 0.16 | Why? |
| Magnetic Resonance Imaging | 4 | 2021 | 6551 | 0.16 | Why? |
| Prednisone | 1 | 2020 | 652 | 0.15 | Why? |
| Treatment Outcome | 7 | 2020 | 51732 | 0.15 | Why? |
| Pancreas Transplantation | 1 | 2017 | 163 | 0.15 | Why? |
| Retrospective Studies | 12 | 2021 | 105322 | 0.14 | Why? |
| Immunoglobulins | 1 | 2020 | 811 | 0.14 | Why? |
| Reoperation | 1 | 2017 | 544 | 0.14 | Why? |
| Creatinine | 1 | 2021 | 1443 | 0.14 | Why? |
| Female | 21 | 2021 | 380317 | 0.14 | Why? |
| Organ Transplantation | 2 | 2020 | 2616 | 0.14 | Why? |
| Patient Selection | 2 | 2019 | 4560 | 0.13 | Why? |
| Patient Preference | 1 | 2021 | 750 | 0.13 | Why? |
| Surgeons | 2 | 2018 | 2233 | 0.13 | Why? |
| Living Donors | 1 | 2018 | 652 | 0.13 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.12 | Why? |
| Troponin I | 1 | 2021 | 1298 | 0.12 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.11 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.11 | Why? |
| Immunization | 1 | 2021 | 2019 | 0.11 | Why? |
| Donor Selection | 1 | 2018 | 804 | 0.11 | Why? |
| Viral Load | 3 | 2020 | 15850 | 0.10 | Why? |
| Longitudinal Studies | 3 | 2020 | 9893 | 0.10 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Vascular Surgical Procedures | 1 | 2018 | 882 | 0.09 | Why? |
| Physician's Role | 1 | 2018 | 853 | 0.09 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.09 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.09 | Why? |
| Kidney | 2 | 2019 | 3648 | 0.09 | Why? |
| Attitude to Health | 1 | 2021 | 2002 | 0.08 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.08 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.08 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.08 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.08 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2017 | 1380 | 0.08 | Why? |
| Pregnancy Complications | 1 | 2017 | 1388 | 0.08 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.07 | Why? |
| Brain Ischemia | 1 | 2020 | 2813 | 0.07 | Why? |
| Adult | 12 | 2020 | 244371 | 0.07 | Why? |
| Liver Transplantation | 1 | 2021 | 2864 | 0.07 | Why? |
| Cytomegalovirus Infections | 1 | 2011 | 667 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.07 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.07 | Why? |
| Young Adult | 6 | 2020 | 93724 | 0.07 | Why? |
| Patient Care Team | 1 | 2018 | 3556 | 0.06 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2017 | 1969 | 0.06 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.06 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| Biological Products | 1 | 2017 | 2331 | 0.06 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.06 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.06 | Why? |
| Pyramidal Tracts | 1 | 2020 | 66 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Interdisciplinary Communication | 2 | 2018 | 1425 | 0.05 | Why? |
| Microradiography | 1 | 2018 | 1 | 0.05 | Why? |
| Confusion | 1 | 2020 | 256 | 0.05 | Why? |
| Pyridoxine | 1 | 2018 | 12 | 0.05 | Why? |
| Meningitis | 1 | 2020 | 163 | 0.05 | Why? |
| Psychomotor Agitation | 1 | 2020 | 208 | 0.05 | Why? |
| Histocompatibility Testing | 1 | 2019 | 219 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Osteoblasts | 1 | 2018 | 87 | 0.04 | Why? |
| Transaminases | 1 | 2018 | 152 | 0.04 | Why? |
| Consciousness Disorders | 1 | 2020 | 335 | 0.04 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.04 | Why? |
| Everolimus | 1 | 2019 | 215 | 0.04 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.04 | Why? |
| Stroke | 1 | 2020 | 8839 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.04 | Why? |
| Bone Density | 1 | 2018 | 335 | 0.04 | Why? |
| Urine | 1 | 2017 | 469 | 0.04 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.03 | Why? |
| Allografts | 1 | 2017 | 761 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Antibodies, Neutralizing | 2 | 2018 | 25288 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Encephalitis | 1 | 2020 | 797 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Survival Rate | 2 | 2020 | 9206 | 0.03 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2018 | 1706 | 0.03 | Why? |
| Ganciclovir | 1 | 2011 | 97 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Cooperative Behavior | 1 | 2018 | 1216 | 0.02 | Why? |
| Headache | 1 | 2020 | 2257 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.02 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.02 | Why? |
| Epitopes | 1 | 2019 | 4113 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.02 | Why? |
| Administration, Oral | 1 | 2011 | 2340 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2017 | 3803 | 0.02 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.02 | Why? |
| Communication | 1 | 2021 | 5206 | 0.02 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Renal Dialysis | 1 | 2018 | 4358 | 0.01 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.01 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Antiviral Agents | 1 | 2011 | 41703 | 0.00 | Why? |